NasdaqCM - Nasdaq Real Time Price USD

Forte Biosciences, Inc. (FBRX)

12.25
+0.30
+(2.51%)
At close: June 10 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
44,922
36,602
32,486
13,896
21,486
Operating Income
-44,922
-36,602
-32,486
-13,896
-21,486
Net Non Operating Interest Income Expense
--
1,314
1,124
162
--
Other Income Expense
-106
-190
-114
-145
-222
Pretax Income
-43,714
-35,478
-31,476
-13,879
-21,708
Net Income Common Stockholders
-43,714
-35,478
-31,476
-13,879
-21,708
Diluted NI Available to Com Stockholders
-43,714
-35,478
-31,476
-13,879
-21,708
Basic EPS
-9.51
-12.17
-24.92
-20.00
-38.75
Diluted EPS
-9.51
-12.17
-24.92
-20.00
-38.75
Basic Average Shares
5,304.81
2,915.89
1,262.84
695.34
558.71
Diluted Average Shares
5,304.81
2,915.89
1,262.84
695.34
558.71
Total Operating Income as Reported
-44,922
-36,602
-32,486
-13,896
-21,486
Total Expenses
44,922
36,602
32,486
13,896
21,486
Net Income from Continuing & Discontinued Operation
-43,714
-35,478
-31,476
-13,879
-21,708
Normalized Income
-43,714
-35,478
-31,476
-13,879
-21,708
Interest Income
--
1,314
1,124
162
--
Net Interest Income
--
1,314
1,124
162
--
EBIT
-44,922
-36,602
-32,486
-13,896
-21,486
EBITDA
-44,879
-36,563
-32,477
-13,896
-21,450
Reconciled Depreciation
43
39
9
0
36
Net Income from Continuing Operation Net Minority Interest
-43,714
-35,478
-31,476
-13,879
-21,708
Total Unusual Items Excluding Goodwill
0
--
--
--
0
Total Unusual Items
0
--
--
--
0
Normalized EBITDA
-44,879
-36,563
-32,477
-13,896
-21,450
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/13/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WHWK Whitehawk Therapeutics, Inc.
1.9900
+1.53%
 
JSPR Jasper Therapeutics, Inc.
5.77
-2.86%
 
COYA Coya Therapeutics, Inc.
5.63
-4.25%
 
DSGN Design Therapeutics, Inc.
4.0100
+2.56%
 
MRKR Marker Therapeutics, Inc.
1.6900
-1.74%
 
OVID Ovid Therapeutics Inc.
0.3211
-3.05%
 
ANTX AN2 Therapeutics, Inc.
1.1100
-0.89%
 
VOR Vor Biopharma Inc.
0.2295
+2.96%
 
ADXS Ayala Pharmaceuticals, Inc.
0.0335
0.00%
 
ZYME Zymeworks Inc.
13.07
+4.98%